Financial News · Live Terminal

Page 1538 of 2468

Humanwell Healthcare Secures US FDA Nod Approval for Generic Fertility Drug

Humanwell Healthcare (SHA:600079) unit has secured U.S. Food and Drug Administration approval for its generic version of the fertility drug cetrorelix acetate injection.The injection is a fertility treatment used to prevent premature luteinizing hormone surges in women undergoing controlled ovarian stimulation, according to a Thursday filing with the Shanghai bourse.Shares of the pharmaceutical company declined 1% in recent trade.

SHA:600079

Asia55d ago

WNC Logs NT$1.13 Billion Profit in Q1; Shares Rally 10%

WNC (TPE:6285) posted a profit attributable to owners of NT$1.13 billion, or NT$2.36 per share, in the first quarter of the year, according to a Wednesday Taiwan bourse filing.Shares jumped about 10% in Thursday's midday trade.Operating revenue stood at NT$29.2 billion, the pharmaceutical company said.The networking and communication products manufacturer did not provide comparative year-ago figures.

TPE:6285

Asia55d ago

Lumos Diagnostics Holdings Receives Milestone Payment for Achieving CLIA Waiver

Lumos Diagnostics Holdings (ASX:LDX) received a milestone payment of $507,377, under its contract with the Biomedical Advanced Research and Development Authority (BARDA) for achieving US Food and Drug Administration (FDA) CLIA waiver for its FebriDx rapid point-of-care test, according to a Thursday Australian bourse filing.The receipt of the payment from BARDA brings the total amount received under the CLIA waiver study to almost $3 million.

ASX:LDX

Asia55d ago

PlaySide Studios Upgrades Fiscal Year 2026 Revenue Guidance; Shares Fall 14%

PlaySide Studios (ASX:PLY) said it now expects fiscal year 2026 revenue to be in the range of AU$50 million to AU$53 million, compared with the prior guidance that fiscal year 2026 revenue would exceed fiscal year 2025 reported revenue of AU$48.7 million, according to a Thursday Australian bourse filing.The company's game, MOUSE: P.I. For Hire, sold around 730,000 units across all platforms since launch, with estimated gross platform sales of $21.4 million. This resulted in around $13 million in reported revenue for the firm.Total wishlists for the game across all platforms have grown to 3 million, up from 2.1 million previously. Gaming console units increased to 50% of total units sold.Its shares fell 14% in recent trading on Thursday.

ASX:PLY

Asia55d ago

New Zealand Shares Rise; Comvita Rights Offer Meets NZ$25 Million Minimum Capital Raise Requirement

New Zealand shares ended higher on Thursday amid a broad-based rise in Asian shares as investors welcomed hopes of a US-Iran peace deal.The S&P/NZX 50 Index rose 0.95% or 125.42 points to close at 13,270.61.Iran said it was reviewing a peace proposal from the US on Wednesday, while US President Donald Trump said it's "very possible" that the two countries will come to a deal, according to a Wednesday Reuters report.In domestic news, the national average rent in New Zealand saw a 1.4% decline to NZ$631 per week in April, compared with NZ$640 per week during the same time last year, and almost NZ$30 below the highest recorded rent in May 2024 of NZ$660 per week.Also, the Organisation for Economic Cooperation and Development said New Zealand should reconsider how often it changes the Reserve Bank's remit, warning that frequent adjustments increase the risk of monetary policy errors, according to a Thursday statement by the international organization.In corporate news, Comvita (NZE:CVT) confirmed that it has satisfied the minimum capital raise requirement of NZ$25 million for its pro-rata renounceable rights offer, driven by strong shareholder participation and Fraser and Neave's nearly 20% shortfall commitment.Santana Minerals' (ASX:SMI, NZE:SMI) wholly owned subsidiary, Matakanui Land, has been approved by New Zealand's Overseas Investment Office to acquire land across Bendigo and Ardgour stations, clearing the way for the company's proposed gold mining project.

^NZ50ASX:SMINZE:CVTNZE:SMI

Asia55d ago

ScinoPharm Taiwan Logs NT$16.5 Million Profit in Q1

ScinoPharm Taiwan (TPE:1789) posted a profit attributable to owners of NT$16.5 million, or NT$0.02 per share, in the first quarter of the year, according to a Wednesday Taiwan bourse filing.Shares slid over 2% in Thursday's midday trade.Operating revenue stood at NT$659.7 million, the pharmaceutical company said.The company did not provide comparative year-ago figures.

TPE:1789

Asia55d ago

Kina Securities Lists Papua New Guinea's First Wholesale Corporate Bond

Kina Securities' (ASX:KSL) 235 million Papua New Guinean Kina, 10-year unsecured subordinated wholesale corporate bond was listed on PNGX Markets, the operator of Papua New Guinea's national stock exchange, on Wednesday, according to a Thursday Australian bourse filing.This represents Papua New Guinea's first listed wholesale corporate bond.The firm expects the issuance to support its balance sheet strength, capital management objectives, and the growth of its banking and financial services operations.Its shares rose 1% in recent trading on Thursday.

ASX:KSL

Asia55d ago

Home First Q4 Profit Soars to INR 1.5 Billion, Beats Estimates

Home First Finance Company India's (NSE:HOMEFIRST, BOM:543259) profit after tax rose to 1.49 billion Indian rupees in the fiscal fourth quarter ended March 31, from 1.05 billion rupees a year ago.Earnings per share came in at 14.22 rupees from 11.45 rupees a year ago, the financial services provider said in a filing to the Indian stock exchanges on Wednesday. The EPS was higher than the 14.08 rupees estimated by the analysts polled by Visible Alpha.Total revenue from operations also increased to 5.01 billion rupees from 2.15 billion rupees a year ago.The company's board recommended a dividend of 5.20 rupees per share of a face value of 2 rupees each for the financial year ended March 31.The company's shares were down 2% in recent trade.

BOM:543259NSE:HOMEFIRST

Asia55d ago

Update: Market Chatter: UAE's XRG Consortium Eyes Shell's AU$2 Billion Stake in Woodside's LNG Project

(Updates to add Woodside's response in the fourth paragraph)The United Arab Emirates-based XRG consortium, a joint venture between Abu Dhabi's state-owned oil and gas major ADNOC and US-based Carlyle, is said to be mulling Shell's AU$2 billion sale of its stake in Woodside Energy Group's (ASX:WDS) North West Shelf liquefied natural gas (LNG) project, according to a Thursday report by The Australian.Woodside has a 33% stake in the joint venture and is its operator, while Shell, Chevron, and BP, along with Mitsui and Mitsubishi, hold the remaining stakes.An XRG spokesperson said that it had a long-term outlook, prioritizing "patient capital" in order to build a global gas business, the report added.Woodside Energy declined to comment on the matter following an email request by.(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)

ASX:WDS

Asia55d ago

Adisyn Secures US Patent For Proprietary Technology For Graphene-Coated Metallic Surfaces, Shares Jump 11%

Adisyn (ASX:AI1) said the US Patent and Trademark Office granted a patent application covering its core proprietary technology for graphene-coated metallic surfaces, according to a Thursday Australian bourse filing.The patent protects both the method of manufacturing graphene-coated metal surfaces and the resulting coated products, as well as devices that include these products.It covers applications across interconnects, back-end-of-line (BEOL) semiconductor devices, nano-electromechanical devices, Organic LEDs, transparent conductive electrodes, and high-conductance interconnects.Its shares jumped 11% in recent trading on Thursday.

ASX:AI1

Asia55d ago

TSMC Unit Invests $42 Million in Corporate Bonds

Taiwan Semiconductor Manufacturing or TSMC's (TPE:2330) unit, TSMC Global, acquired corporate bonds worth about $42.3 million, according to a Wednesday Taiwan Exchange filing.Shares gained about 3% in Thursday's midday trade.The purchases were made between March 17 and May 6 as part of the group's fixed-income investment strategy.The securities investment accounts for about 6.03% of total assets and 8.09% of equity.

TPE:2330

Asia55d ago

Humanwell Healthcare Gets Clinical Trial Approval for Opioid Alternative

Humanwell Healthcare (SHA:600079) unit obtained China's regulatory approval to begin clinical trials for RFUS-188 to treat acute pain, according to a Thursday filing with the Shanghai bourse.The drug targets peripheral kappa opioid receptors without crossing the blood-brain barrier, potentially eliminating the addiction, respiratory depression and other severe side effects of traditional opioidsShares of the pharmaceutical company declined 1% in recent trade.

SHA:600079

Asia55d ago

Tibet Huayu Mining Shareholder to Divest 1% Stake in Company

A Tibet Huayu Mining (SHA:601020) shareholder plans to reduce part of its holdings to meet its own business development needs, according to a Shanghai bourse filing on Thursday.Qinghai Western Rare Precious Metals will offload 8,200,000 shares, or around 1% of the mining company's total shares, between May 29 and Aug. 28.Qinghai Western Rare Precious Metals currently owns 72,336,364 shares, or 8.8% of the company's total shares.

SHA:601020

Asia55d ago

Taiwan Mask Mulls Private Placement of Up to 20 Million Shares; Shares Rally 10%

Taiwan Mask (TPE:2338) board approved a plan to privately place up to 20 million shares in one to three tranches within a year, according to a filing with the Taiwan Exchange on Wednesday.Shares of the photomask manufacturer jumped about 10% in Thursday's midday trade.Proceeds from the offering are earmarked for working capital, factory expansion, machinery and equipment procurement, debt repayment, and other long-term development needs.Potential subscribers may include insider and related parties such as Luminous Rise Investment, TrueLight Corp., Star Fusion Group, and ALi Corp. (TPE:3041), although no final placees have been selected, it said.

TPE:2338

Asia55d ago

BWP Trust Completes Institutional Entitlement Offer

BWP Trust (ASX:BWP) completed the institutional component of its fully underwritten one-for-12 accelerated non-renounceable pro rata entitlement offer at a fixed issue price of AU$3.77 per new security, raising gross proceeds of around AU$122 million, according to a Thursday Australian bourse filing.Its institutional securityholders accounted for a take-up rate of around 98%. The gross proceeds included Wesfarmers' full entitlement of around AU$53 million.Around 32 million new securities will be issued under the institutional entitlement offer at the issue price.The fully underwritten retail component of the entitlement offer is expected to raise around AU$106 million and will open on May 12.

ASX:BWP

Asia55d ago

Willfar IT Bags 223 Million Yuan Worth of Projects in April

Willfar Information Technology (SHA:688100) won projects amounting to 223.2 million yuan in April, according to a Shanghai bourse disclosure on Thursday.The projects included bids won from the State Grid Corporate of China.The electrical energy measurement equipment manufacturer's shares rose less than 2% during the midday trade.

SHA:688100

Asia55d ago

Market Chatter: UAE's XRG Consortium Eyes Shell's AU$2 Billion Stake in Woodside's LNG Project

The United Arab Emirates-based XRG consortium, a joint venture between Abu Dhabi's state-owned oil and gas major ADNOC and US-based Carlyle, is said to be mulling Shell's AU$2 billion sale of its stake in Woodside Energy Group's (ASX:WDS) North West Shelf liquefied natural gas (LNG) project, according to a Thursday report by The Australian.Woodside has a 33% stake in the joint venture and is its operator, while Shell, Chevron, and BP, along with Mitsui and Mitsubishi, hold the remaining stakes.An XRG spokesperson said that it had a long-term outlook, prioritizing "patient capital" in order to build a global gas business, the report added.(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)

ASX:WDS

Research55d ago

Research Alert: CFRA Retains Hold Rating On Shares Of Organon & Co. Following Q1 Results

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We keep our target price at $14.00, based on a P/E of 3.8x our 2027 EPS estimate. We lower our 2026 EPS estimate to $3.40 from $3.62 and maintain our 2027 EPS estimate at $3.71. Organon reported mixed Q1 2026 results, with revenues declining 4% Y/Y to $1,460M (-9% on a constant currency basis), reflecting headwinds across its Women's Health franchise, with sales down 16% Y/Y, particularly for Nexplanon. Yet, the company's biosimilar portfolio delivered robust growth, with revenues advancing 23% Y/Y, led by Hadlima's strong U.S. performance. Looking ahead, the successful closing of the pending Sun Pharmaceutical acquisition will be the key focus. On April 26, the company entered into a definitive merger agreement with Sun Pharmaceutical, which valued Organon at $11.75B. Joseph Morrissey, previously serving as Interim CEO, was appointed to the role on a permanent basis, which eliminates leadership uncertainty during this critical period, in our view.

$OGN

US Markets55d ago

SK Telecom's Q1 Profit Falls Amid Data Breach

SK Telecom's (KRX:017670) attributable profit declined during the first quarter amid the effects of a data breach in the previous year.South Korea's largest wireless telecommunications operator posted net attributable profit of 322.4 billion won, down 11.5% from 364.4 billion won a year earlier, according to a Thursday filing with the Korea Exchange.Basic earnings per share slid to 1,490 won during the quarter from 1,689 won in the year-ago period. Analysts at Visible Alpha estimated diluted earnings per share at 1,297.15 won.Operating revenue slipped 1.4% year over year to 4.392 trillion won from 4.454 trillion won.Mobile service revenue declined 3% to 2.581 trillion won from 2.662 trillion won.Despite the fallout from the data breach in the first quarter of 2025, which led to the loss of about 600,000 subscribers during the period following a cyberattack on its main servers, the telco gained 210,000 handset subscribers in the first three months of 2026.SK Telecom also expanded membership benefits and restructured rates to win more subscribers, it said."These results are attributable to the company's commitment to placing customers at the core of its business and implementing a range of measures to strengthen fundamental competitiveness," SK Telecom said in a press release on Thursday.Broadband revenue grew 3.2% year over year to 1.150 trillion won from 1.114 trillion won as the number of high-speed internet subscribers grew.Artificial intelligence data center revenue surged 89% year over year to 131.4 billion won from 69.4 billion won on higher use rates of its data centers and better revenue contribution from its GPU-as-a-service segment.Operating expenses slipped year over year to 3.855 trillion won from 3.886 trillion won.Capital expenditure jumped 29% to 136.5 billion won from 106 billion won."Going forward, we will make every effort to restore our earnings by generating sustained results," Chief Financial Officer Park Jong-seok said in a statement.SK Telecom's shares declined over 2% in Thursday afternoon trade.

KRX:017670

International55d ago

BOJ Should Continue Rate Hikes in Line with Economic Activity and Prices, Meeting Minutes Show

Bank of Japan (BOJ) members agreed the central bank should continue raising interest rates in line with developments in economic activity and prices amid the ongoing Iran war, minutes of the March meeting showed on Thursday.The Middle East turmoil has caused a surge in oil prices, increasing inflationary pressures and weighing on the economy of countries dependent on fuel imports.The BOJ members said rate hike decisions should be made at each monetary policy meeting, taking into account the achievement of economic activity and price outlook, underlying inflation, and outlook risks.One member said the BOJ should adjust the monetary accommodation degree without long intervals under current financial conditions, where an uptrend in prices is likely to remain.Another member stressed the need to keep underlying inflation from exceeding 2% and said the bank must not hesitate to raise rates unless the economic outlook or wage-setting resolve among small and medium-sized firms deteriorates sharply.In March, the BoJ board voted 8-1 to keep the policy rate at around 0.75%, with one member dissenting in favor of a hike to 1%.

Nikkei 225

Showing 30741-30760 of 49350

US Markets55d ago

SK Telecom's Q1 Profit Falls Amid Data Breach

KRX:017670